PharmaState Is Official Media Partner For DUPHAT 2022. Click the banner to explore more...spot_imgspot_imgspot_img

Dilip Shanghvi drew a salary of Rs 1/- during the year 2018-19

-

Mr. Dilip Shanghvi, took a 99% cut in his remuneration in 2018-19 when the Sun Pharma earnings grew by 27%.

Among peers, Shanghvi was one of the lowest-paid CEOs. His remuneration in 2017-18 was Rs 3.36 crore (including a salary of Rs 2.79 cr). He drew a salary of ~ Rs 1/- during 2018-19 as per Sun Pharma’s annual report.

The valuation of Dilip Shanghvi shareholding which is 9.6 % in Sun Pharma on 31st July 2019 was Rs. 9830 crore.

PharmaState Blog
This is a platform for people working in the pharmaceuticals industry for Discussions, Jobs, News updates, Professional Profile display space and company business pages. PharmaState DNA is having four pillars: Quality, Transparency, Innovation & Benchmarks.

Share this article

Recent posts

Popular categories

Leave a Reply

Recent comments

Business Alnavedic on History of Indian Pharma Industry
Ahmed Mohamed Elkhodragy on MACO Calculation
Jennifer Osunde on DEFECTS IN UNCOATED TABLETS
Vinod on DEVIATION
Rajib ghose on TOOLING FOR TABLETING
K. SRinivasula Reddy on Quality Agreements – PART 2
Sunil Kumar M on SITE ACCEPTANCE TEST (SAT)
Khalid on IQ Protocol
Khalid on IQ Protocol
Nagabooshanam on Calibration of Reactor
PharmaState Blog on SOP for Sampling
Swapnil Khodake on TOOLING FOR TABLETING
%d bloggers like this: